Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Trotman
Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety Analysis of Australasian Leukaemia & Lymphoma Group Nhl29: A Phase Ii Study of Ibrutinib, Rituximab and Mini-Chop in Very Elderly Patients With Newly Diagnosed DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PATIENT-REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB-RITUXIMAB IN THE INNOVATE STUDY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
WhiMSICAL (WALDENSTRÖM'S MACROGLOBULINEMIA STUDY INVOLVING CArt-wheeL): A GLOBAL PATIENT-DERIVED DATA REGISTRY MAPPING TREATMENT AND QUALITY OF LIFE
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bruton's Tyrosine Kinase (Btk) Inhibitor BGB-3111 Demonstrates High Very Good Partial Response (Vgpr) Rate in Patients With Waldenström Macroglobulinemia (Wm)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
First-Line Treatment of Inhl or MCL Patients With Br or R-Chop/R-Cvp: Results of the Bright 5-Year Follow-Up Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology